iContraception

com.itiox.icontraception

View detailed information for iContraception — ratings, download counts, screenshots, pricing and developer details. See integrated SDKs and related technical data.

Total installs
106.1K(106,181)
Rating
4.5(3 reviews)
Released
July 16, 2013
Last updated
September 23, 2018
Category
Medical
Developer
Javier Alvargonzalez
Developer details
Name
Javier Alvargonzalez
E-mail
contact@itiox.com
Website
unknown
Country
Spain
Address
C/ Maestro Jiménez, 41010 Sevilla (Spain)
iContraception Header - AppWisp.com

Screenshots

iContraception Screenshot 1 - AppWisp.com
iContraception Screenshot 2 - AppWisp.com
iContraception Screenshot 3 - AppWisp.com
iContraception Screenshot 4 - AppWisp.com

Description

This App is intended for health-care providers.

It contains recommendations intended to help health-care providers determine the safe use of contraceptive methods among women with various characteristics, habits and medical conditions.

Providers can select conditions according to the patient, and the App assigns automatically a category for each method. Generally speaking and with medical criteria, categories 1 and 2 permit the use of a treatment in any case or with some considerations and categories 3 and 4 advise against or forbid its usage. For more information consult this App or its documentation.

The recommendations refer to contraceptive methods being used for contraceptive purposes; the recommendations do not consider the use of contraceptive methods for treatment of medical conditions because the eligibility criteria in these cases may differ.

The recommendations and all information contained in this App, are based on the document "Medical eligibility criteria for contraceptive use, Fourth edition 2009" published by WHO ("World Health Organization"). Adaptations and modifications to update its contents has been made following the conferences of the "Sociedad Española de Contracepción" (Spanish Society for Contraception) and the CDC document "U.S. Medical Eligibility Criteria for Contraceptive Use, 2010".